PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER INCIDENCE IN PRE-VACCINATION AND THE INITIAL VACCINATION PERIODS IN THE REPUBLIC OF SAKHA (YAKUTIA)

被引：0
|
作者：
Ignatieva, M. E.
Lyalina, L., V
Smetanina, V. D.
Karpova, I. I.
Afanasieva, L. N.
机构：
来源：
YAKUT MEDICAL JOURNAL | 2012年 / 03期
关键词：
human papillomavirus infection; cervical cancer; morbidity; prevalence; vaccination;
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The research aims at studying patterns and regional characteristics of morbidity and incidence of various papillomavirus infection and cervical cancer forms in the Republic of Sakha (Yakutia) in the pre-vaccination period and the first years of vaccination against this pathology. It is established that the studied periods do not show any significant differences or decreasing trend in anogenital (venereal) warts morbidity. The study revealed higher (by 1/6-2 times) incidence of high-risk HPV of type 16 in women, compared with men. There was no decrease in type 16 and 18 HPV incidence in 2008-2011 (the period of introducing low vaccination coverage), compared with the year 2007. There is a trend for increased CC morbidity in women aged 30-44 years.
引用
收藏
页码：118 / 125
页数：8
相关论文
共 50 条
  • [21] Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control
    Franco, EL
    Harper, DA
    VACCINE, 2005, 23 (17-18) : 2388 - 2394
  • [22] Mortality attributable to influenza in pre-vaccination and post-vaccination periods in Argentina: an ecological study (2002-2016)
    Sarrouf, Elena B.
    Souza-Santos, Reinaldo
    Cruz, Oswaldo Goncalves
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2019, 43
  • [23] Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study
    Ucakar, Veronika
    Poljak, Mario
    Klavs, Irena
    VACCINE, 2012, 30 (02) : 116 - 120
  • [24] Increased incidence of cervical cancer in Sweden: an unlikely link with human papillomavirus (HPV) vaccination
    Jorgensen, Lars
    Gotzsche, Peter Christian
    Jefferson, Tom
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2019, 45 (04) : 303 - 304
  • [25] Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in germany
    Schneider, Achim
    Schwarz, Tino F.
    Hammerschmidt, Thomas
    Siebert, Uwe
    MEDIZINISCHE KLINIK, 2007, 102 (07) : 515 - 523
  • [26] Prospects for cervical cancer prevention by human papillomavirus vaccination
    Schiller, John T.
    Lowy, Douglas R.
    CANCER RESEARCH, 2006, 66 (21) : 10229 - 10232
  • [27] Strategies for the prevention of cervical cancer by human papillomavirus vaccination
    Williamson, AL
    Passmore, JA
    Rybicki, EP
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2005, 19 (04) : 531 - 544
  • [28] Clarification on the impact of cervarix vaccination on human papillomavirus infection and cervical cancer in the United Kingdom
    Brown, Darron
    Kulkarni, Amit Sharad
    Pillsbury, Matt
    Luxembourg, Alain
    Saah, Alfred
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (07) : 1940 - 1942
  • [29] Perception of Human Papillomavirus Infection, Cervical Cancer and HPV Vaccination in North Indian Population
    Hussain, Showket
    Nasare, Vilas
    Kumari, Malasha
    Sharma, Shashi
    Khan, Mohammad Aijaz
    Das, Bhudev C.
    Bharadwaj, Mausumi
    PLOS ONE, 2014, 9 (11):
  • [30] Human papillomavirus (HPV) infection, cervical cancer and vaccination against HPV:: a Nordic perspective
    Kjaer, Susanne Kruger
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2007, 86 (11) : 1286 - 1289
12345